| Bioactivity | CP-506 (compound 26) is an anticancer compound and a substrate for nitroreductase and CYP oxidoreductases. CP-506 has anticancer activity[1]. |
| Target | Nitroreductase, CYP oxidoreductase |
| Name | CP-506 |
| CAS | 2227303-52-6 |
| Formula | C19H29BrN4O8S2 |
| Molar Mass | 585.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ashoorzadeh A et al. Design and Biological Evaluation of Piperazine-Bearing Nitrobenzamide Hypoxia/GDEPT Prodrugs: The Discovery of CP-506. ACS Med Chem Lett. 2023 Oct 5;14(11):1517-1523. |
CP-506
CAS: 2227303-52-6 F: C19H29BrN4O8S2 W: 585.49
CP-506 (compound 26) is an anticancer compound and a substrate for nitroreductase and CYP oxidoreductases. CP-506 has an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.